AAGP eNews
Dec. 2, 2014

Have you voted yet? AAGP Elections for the 2015 Board of Directors are open!
Make your voice heard. Vote in the 2015 AAGP Board Elections today! You can see a list of candidates, read their statements and vote online here.More

Is your AAGP membership about to expire?
All but a few of AAGP current memberships expire on December 31, 2014. You don't want to miss out on upcoming issues of the American Journal of Geriatric Psychiatry or important 2015 Annual Meeting announcements! So, if you've not already done so, remember to renew your AAGP membership today.More

American Journal of Geriatric Psychiatry's Editor-In-Chief promoted to senior associate dean at UC San Diego
In November, Dr. David Brenner, Vice Chancellor, UC San Diego Health Sciences and Dean of the School of Medicine announced that Dr. Dilip V. Jeste, Distinguished Professor of Psychiatry and Neurosciences, has been elevated to senior associate dean for Healthy Aging and Senior Care. In the few short months since Dr. Jeste assumed the roles of associate dean for Healthy Aging and Senior Care – the university’s first – and director of the newly established Center on Healthy Aging and Senior Care, he has forged remarkable progress toward establishing UC San Diego as a focus and leader in addressing the diverse challenges and opportunities of aging. UC San Diego hosted its first national think tank on the topic November 14-16, attracting experts from around the country and world to discuss the demographics of aging, new geriatric health care models, an older workforce and senior-centric technologies. More

NC Psychiatric Association seeks award nominations
The Psychiatric Foundation of North Carolina invites AAGP to submit nominations for the 2015 V. Sagar Sethi, M.D. Mental Health Research Award. This national award seeks to honor a scientist for significant contributions to basic research in the neurosciences, psychology or pharmacology at a molecular, cellular or behavioral level. For more information and to nominate or apply, click here. More

Too few Americans undergo dementia screening
HealthDay via WebMD
More than half of Americans with dementia have never undergone screening of their thinking and memory skills, a new study suggests. As reported online Nov. 26 in Neurology, "approximately 1.8 million Americans over the age of 70 with dementia have never had an evaluation of their cognitive [mental] abilities," study author Dr. Vikas Kotagal, of the University of Michigan Health System in Ann Arbor, said in a journal news release.More

Brain's dementia weak spot identified
The brain has a weak spot for Alzheimer's disease and schizophrenia, according to U.K. scientists who have pinpointed the region using scans. The brain area involved develops late in adolescence and degenerates early during aging. At the moment, it is difficult for doctors to predict which people might develop either condition. The findings, in the journal PNAS, hint at a potential way to diagnose those at risk earlier, experts say. Although they caution that "much more research is needed into how to bring these exciting discoveries into the clinic."More

AstraZeneca and Lilly move Alzheimer's drug into big trial
AstraZeneca and Eli Lilly said they had started a large trial of their experimental Alzheimer's drug, seen as a promising, but still risky, approach for slowing the memory-robbing disease. The pivotal Phase II/III clinical trial will involve more than 1,500 patients with early Alzheimer's, the first one of which has now been enrolled. The study is expected to complete in May 2019, according to the clinicaltrials.gov website.More

Report: Regular coffee consumption could keep Alzheimer's at bay
The Huffington Post
There's good news and bad news, coffee drinkers. A new report says the liquid gold an estimated three in five Americans drinks every day could be helpful in curbing the risk for Alzheimer's disease — but only on a short-term basis. The analysis of coffee-related Alzheimer's research was presented by the Institute for Scientific Information on Coffee, a nonprofit that studies the health effects of coffee, at the Alzheimer Europe conference.More

Targeting sleep-wake protein may prevent Alzheimer's
Medical News Today
A new study reported in The Journal of Experimental Medicine suggests an approach to preventing Alzheimer's disease may lie in targeting orexin — a small protein that arouses the brain from sleep. Researchers from the School of Medicine at Washington University in St. Louis came to this conclusion after they found eliminating orexin in mice made them sleep longer and significantly slowed the production of brain plaques. More

Imaging shows brain connection breakdown in early Alzheimer's disease
Medical Xpress
Changes in brain connections visible on MRI could represent an imaging biomarker of Alzheimer's disease, according to a new study presented at the annual meeting of the Radiological Society of North America. For the study, researchers looked at the brain's structural connectome, a map of white matter tracts that carry signals between different areas of the brain. More

The mystery of memory: Unveiling FXR1P
By Dorothy L. Tengler
Ordinary human memory is a mess. Most of us can recall the major events in our lives but may have to hear a phone number a dozen times before we can repeat it. It's easy for us to forget things we've learned — like the periodic table. The fundamental problem is the seemingly haphazard fashion in which our memories are organized. Neuroscientific research suggests that our brains don't use a fixed-address system like computers, and memories tend to overlap, combine and disappear for reasons no one yet understands. More

Bilingualism has protective effect in delaying Alzheimer's disease symptoms
News Medical
A new study at Ghent University has established that the symptoms of Alzheimer's disease manifest themselves about four to five years later in bilinguals as opposed to monolinguals. In bilinguals, the disease onset was estimated at the age of 77, while in monolinguals, this was at the age of 73. More